Table 3.

Self-reported RBD clinical status

Secondary outcome measures				p-value
	Baseline	5-HTP	Placebo	Baseline vs 5-HTP vs Placebo	Baseline vs 5-HTP	Baseline vs Placebo
CGI	3.23±0.59	2.76±0.83	2.53±0.87	0.001*	<0.05**	<0.001**
Self-reported frequency	2.66±2.05	1.60±1.18	1.53±1.06	ns	ns	ns

Data are presented as mean and standard deviation (S.D); CGI, clinical global impression; ns, not significant. *Repeated measures one-way ANOVA; ** post-hoc analysis